Peptide Academy · Approved peptides · Education only
Tesamorelin: What FDA Approved, Explained Simply
By BioLabs Research · Peptide Academy › Approved Peptides
Here's a peptide with a very specific job. Some adults living with HIV develop extra fat stored deep inside the belly, around the organs. Doctors call this lipodystrophy. Tesamorelin is the FDA-approved peptide medicine whose label addresses it.
On this page we'll keep it simple: what tesamorelin is, what it does according to the official FDA label, and exactly what FDA approved. Nothing here is advice on using a medicine. Approved medicines are prescribed by licensed clinicians, and the official label is always the controlling text.
What it is
Tesamorelin is a lab-made version of growth hormone-releasing hormone (GHRH), also called growth hormone-releasing factor (GRF). GHRH is a natural peptide made in the hypothalamus, a small control centre at the base of the brain. Its job is to tell the pituitary gland, the body's hormone 'dispatcher', when to release growth hormone. Tesamorelin keeps the same message but has a small chemical tweak that makes it more stable than the natural version.
What it does
According to section 12.1 of the FDA label, tesamorelin binds and stimulates human GRF receptors in lab tests with similar potency to the body's own GRF. GRF acts on pituitary cells called somatotrophs, which then make and release the body's own growth hormone in pulses. So tesamorelin doesn't contain growth hormone. It works one step upstream, by sending the 'release it' signal.
For a deeper dive, see the peer-reviewed review: Drugs 2011 — 'Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy' (PubMed 21668043).
What FDA approved
Labelled indication: Reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy.
The label lists limitations: long-term cardiovascular safety has not been established; it is not indicated for weight-loss management (the label calls its effect weight-neutral); and there are no data that it improves adherence to antiretroviral therapy.
Regulatory status at a glance
| Item | Status | Source |
|---|---|---|
| Application | BLA 022505 | Drugs@FDA |
| Original approval date | November 10, 2010 | openFDA |
| Labelled indication | As quoted above | DailyMed |
| Boxed warning | None | DailyMed |
| 503A bulks list | Not applicable: this is an FDA-approved product | — |
A common misunderstanding
A common mix-up: people sometimes describe tesamorelin as a general 'growth hormone peptide'. Its FDA approval is much narrower than that. It covers one condition, in one patient group, as written on the label.
What FDA approval actually means
Here's the part most people get wrong. FDA approval is narrow. It covers a specific product, from a specific manufacturer, for a specific use, in a specific group of patients, with a specific label. The approval does not belong to the molecule floating around in the world. A chemical with the same name, sold by someone else for any other purpose, is not an approved drug. That's why we quote the label's own indication and nothing more.
How we checked these facts
Every regulatory fact on this page comes from an official U.S. government source: the Drugs@FDA database (and its openFDA API) for the application number and approval date, and the current FDA label on DailyMed for the indication, boxed warning and mechanism. Mechanism background also comes from a peer-reviewed review indexed in PubMed. We don't reproduce usage instructions from labels. This is an education page, not a guide to using any medicine.
Why approved peptides matter for peptide science
Approved peptides prove that peptide research can turn into real medicines. They also show how high the bar is: controlled human trials, manufacturing inspections, a written label, and safety monitoring that continues after approval. Most peptides you read about online never got anywhere near that bar. Chapter 7 of the Academy explains where the line sits.
FAQ
Is tesamorelin a growth hormone?
No. Per the FDA label, it is a GHRH analogue. It signals the pituitary to release the body's own growth hormone.
Is tesamorelin approved for weight loss?
No. The FDA label states it is not indicated for weight-loss management.
Is this page medical advice?
No. It is education only. Talk to a licensed healthcare professional about any medicine.
References: Drugs@FDA; openFDA; DailyMed label; PubMed review.